Catalyst Ranks in Top of Annual List
For fourth consecutive year, CRO recognized for its growth and culture.
RALEIGH, N.C., 8 November 2023 – Catalyst Clinical Research ranked ninth in the Triangle Business Journal’s (TBJ) Fast 50, which was announced Nov. 8. This is the fourth consecutive year Catalyst has been awarded this accolade and the third time it has ranked in the top 10. The TBJ’s designation recognizes the fastest-growing privately held companies in North Carolina’s Research Triangle region.
Catalyst’s continued growth highlights its commitment to a people-driven culture. In 2022, Catalyst expanded its presence in the European market by acquiring Aptus Clinical, and in 2023, the company further extended its reach into the Asia-Pacific region with its successful acquisition of Genpro Research, marking two years of significant expansion for Catalyst. Leaders attribute this growth to the company’s people-first and value-centered culture.
“Catalyst is honored to receive this recognition as a TBJ Fast 50 company along with many other important businesses,” said Deborah Jones-Hertzog, Chief Information Officer for Catalyst Clinical Research. “We would like to thank our entire Catalyst team, loyal clients, and trusted partners, as we are here because of your belief in Catalyst and the work we do.”
Catalyst continues to offer innovative solutions globally with expert teams supporting clinical research for small to and midsized biopharma customers.
About Catalyst Clinical Research
Catalyst Clinical Research is a culture-first clinical research organization (CRO) with locations throughout the United States, Europe, and the Asia Pacific region. Catalyst provides the global biopharmaceutical and biotechnology industries with custom clinical trial solutions through its two established brands: Catalyst Oncology and Catalyst Flex. With over 1,000 staff, Catalyst’s purpose-driven culture powers therapeutic advances by leveraging expert teams and innovative technologies. Visit us online at CatalystCR.com, a leading healthcare and life sciences investment firm.
Contact
Juliette Almond, Senior Director, Marketing and Communications
e: juliette.almond@catalystcr.com t: +44 1295 585733
